Development of a new neutralization test for measles virus

Journal of Virological Methods

Volumn 142, Issue 1-2, 2007, Pages 15-20

  Fujino, Motoko ^a   Yoshida, Naoko ^b   Kimura, Keiko ^b   Zhou, Jianhui ^a,c   Motegi, Yoshie ^d   Komase, Katsuhiro ^d   Nakayama, Tetsuo ^a  

^a KITASATO UNIVERSITY   (Japan)

^b KEIO UNIVERSITY   (Japan)

^c Jilin Provincial Center for Disease Prevention and Control   (China)

^d KITASATO INSTITUTE   (Japan)

Author keywords

Enzyme linked immunosorbent assay (EIA); Hemagglutination inhibition (HI); Neutralization test (NT); Particle agglutination (PA); Recombinant measles virus

Indexed keywords

GREEN FLUORESCENT PROTEIN;

AGGLUTINATION TEST; ANIMAL CELL; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; ENZYME IMMUNOASSAY; FLUORESCENCE; HEMAGGLUTINATION INHIBITION; HUMAN; INTERMETHOD COMPARISON; JAPAN; MEASLES; MEASLES VIRUS; NONHUMAN; PARTICLE AGGLUTINATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RELIABILITY; SERODIAGNOSIS; SEROEPIDEMIOLOGY; ULTRAVIOLET RADIATION; VIRUS DETECTION; VIRUS PLAQUE; VIRUS RECOMBINANT; VIRUS RESISTANCE;

AGGLUTINATION TESTS; ANIMALS; ANTIBODIES, VIRAL; ANTIGENS, VIRAL; CELL LINE; CERCOPITHECUS AETHIOPS; CHILD; CYTOPATHOGENIC EFFECT, VIRAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; GREEN FLUORESCENT PROTEINS; HEMAGGLUTINATION INHIBITION TESTS; HUMANS; MEASLES; MEASLES VIRUS; NEUTRALIZATION TESTS; PLAQUE ASSAY; RECOMBINANT PROTEINS; VERO CELLS;

MEASLES VIRUS;

EID: 34247113710     PISSN: 01660934     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jviromet.2007.01.001     Document Type: Article

References (19)

1. Bouche F., Ammerlaan W., Berthet F., Houard S., Schneider F., and Muller C.P. Immunosorbent assay based on recombinant hemagglutinin protein produced in a high-efficiency mammalian expression system for surveillance of measles immunity. J. Clin. Microbiol. 36 (1998) 721-726
2. de Swart R.L., Yuksel S., and Osterhaus A.D. Relative contributions of measles virus hemagglutinin- and fusion protein-specific serum antibodies to virus neutralization. J. Virol. 79 (2005) 11547-11551
3. Griffin D.E., and Bellini W.J. Measles virus. In: Knipe D.M., and Howley P.M. (Eds). Fields virology. fourth ed. (2001), Williams & Wilkins, Lippincott, Philadelphia 1267-1312
4. Kumada A., Komase K., and Nakayama T. Recombinant measles AIK-C strain expressing current wild-type hemagglutinin protein. Vaccine 22 (2004) 309-316
5. Lee M.S., Cohen B., Hand J., and Nokes D.J. A simplified and standardized neutralization enzyme immunoassay for the quantification of measles neutralizing antibody. J. Virol. Methods 78 (1999) 209-217
6. Miyamura K., Sato T.A., Sakae K., Kato N., Ogino T., Yashima T., Sasagawa A., Chikahira M., Itagaki A., Katsuki K., Matsunaga Y., Utagawa E., Takeda N., Inouye S., and Yamazaki S. Comparison of gelatin particle agglutination and hemagglutination inhibition tests for measles seroepidemiology studies. Arch. Virol. 142 (1997) 1963-1970
7. Mori T., Sasaki K., Hashimoto H., and Makino S. Molecular cloning and complete nucleotide sequence of genomic RNA of the AIK-C strain of attenuated measles virus. Virus Genes 7 (1993) 67-81
8. Nakayama T., Zhou J., and Fujino M. Current status of measles in Japan. J. Infect. Chemother. 9 (2003) 1-7
9. Nakayama T., Komase K., Uzuka R., Hoshi A., and Okafuji T. Leucine at position 278 of the AIK-C measles virus vaccine strain fusion protein is responsible for reduced syncytium formation. J. Gen. Virol. 82 (2001) 2143-2150
10. Neumann P.W., Weber J.M., Jessamine A.G., and O'Shaughnessy M.V. Comparison of measles antihemolysin test, enzyme-linked immunosorbent assay, and hemagglutination inhibition test with neutralization test for determination of immune status. J. Clin. Microbiol. 22 (1985) 296-298
11. Ratnam S., Gadag V., West R., Burris J., Oates E., Stead F., and Bouilianne N. Comparison of commercial enzyme immunoassay kits with plaque reduction test for detection of measles virus antibody. J. Clin. Microbiol. 33 (1995) 811-815
12. Schneider H., Spielhofer P., Kaelin K., Dotsch C., Radecke F., Sutter G., and Billeter M.A. Rescue of measles virus using a replication-deficient vaccinia-T7 vector. J. Virol. Methods 64 (1997) 57-64
13. Strebel P.M., Papania M.J., and Halsey N.A. Measles vaccine. In: Plotkin S.A., and Orenstein W.A. (Eds). Vaccine. fourth ed. (2004), Saunders, Philadelphia 389-440
14. Takeda M., Takeuchi K., Miyajima N., Kobune F., Nagata N., Suzuki Y., and Tashiro M. Recovery of pathogenic measles virus from cloned cDNA. J. Virol. 74 (2000) 6643-6647
15. van den Hof S., van Gageldonk-Lafeber A.B., van Binnendijk R.S., van Gageldonk P.G., and Berbers G.A. Comparison of measles virus-specific antibody titers as measured by enzyme-linked immunosorbent assay and virus neutralization assay. Vaccine 21 (2003) 4210-4214
16. Ward B.J., Aouchiche S., Martel N., Bertley F.M.N., Bautista-Lopez N., Serhir B., and Ratna m.S. Measurement of measles virus-specific neutralization of the syncytium inhibition assay in comparison with the plaque reduction neutralization test. Diagn. Microbial. Infect. Dis. 33 (1999) 147-152
17. Whittle H.C., Mann G., Eccles M., O'Neill K., Jupp L., Hanlon P., Hanlon L., and Marsh V. Effects of dose and strain of vaccine on success of measles vaccination of infants aged 4-5 months. Lancet 30 (1988) 963-966
18. WHO, 2003. WHO-recommended surveillance standard of measles. WHO-recommended standards for surveillance of vaccine-preventable diseases, 13-17.
19. WHO. Progress in reducing global measles deaths: 1999-2004. Wkly. Epidemiol. Rec. 81 (2006) 90-94